Jorg Westermann

Sylter Str. 2
Berlin, BE 13353, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Imaging-based response criteria in oncology : Assessment of response to treatment in solid tumors and lymphomas

Imaging-based response criteria in oncology : Assessment of response to treatment in solid tumors and lymphomas

Journal: Radiologie (Heidelberg, Germany)

Published: February 06, 2026

Rapid and Reproducible Karyotyping with Long Read Sequencing in AML Patients.

Rapid and Reproducible Karyotyping with Long Read Sequencing in AML Patients.

Journal: Blood advances

Published: February 02, 2026

Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial.

Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial.

Journal: Blood

Published: January 23, 2026

A phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

A phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

Journal: Blood

Published: July 09, 2025

Phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

Phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

Journal: Blood

Published: July 09, 2025

Bispecific BAFF-R/BCMA CAR T cells control growth of heterogeneous plasma cells in multiple myeloma.

Bispecific BAFF-R/BCMA CAR T cells control growth of heterogeneous plasma cells in multiple myeloma.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 31, 2025

Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy.

Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy.

Journal: Blood cancer journal

Published: June 02, 2024

Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG).

Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG).

Journal: HemaSphere

Published: April 12, 2024

The XENONnT dark matter experiment.

The XENONnT dark matter experiment.

Journal: The European physical journal. C, Particles and fields

Published: February 23, 2024

Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients.

Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients.

Journal: European journal of haematology

Published: December 13, 2023

Effective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base assessment.

Effective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base assessment.

Journal: Palliative care and social practice

Published: December 05, 2023

Diagnosing recipient- vs. donor-derived posttransplant myelodysplastic neoplasm via targeted single-cell mutational profiling.

Diagnosing recipient- vs. donor-derived posttransplant myelodysplastic neoplasm via targeted single-cell mutational profiling.

Journal: Med (New York, N.Y.)

Published: October 10, 2023

Showing 1-12 of 76

Last Updated: 09/26/2026